Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Park, Dae Won ^a   Sohn, Jang Wook ^a   Cheong, Hee Jin ^a   Kim, Woo Joo ^a   Kim, Min Ja ^a   Kim, Je Hyeong ^a   Shin, Chol ^b  

^a Korea University College of Medicine   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; CASPOFUNGIN; FLUCONAZOLE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; COCCIDIOIDOMYCOSIS; DRUG RESPONSE; FACE DISORDER; HUMAN; IMMUNOCOMPETENCE; INFECTIOUS PNEUMONIA; KOREA; LUNG INFILTRATE; MALE; NONHUMAN; RASH; SEROLOGY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TRUNK;

ADULT; ANTIFUNGAL AGENTS; COCCIDIOIDOMYCOSIS; DRUG THERAPY, COMBINATION; ECHINOCANDINS; FLUCONAZOLE; HUMANS; KOREA; LUNG DISEASES, FUNGAL; MALE; PEPTIDES, CYCLIC; PNEUMONIA;

EID: 33646083439     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-26     Document Type: Article

References (15)

1. Stevens DA: Coccidioidomycosis. N Engl J Med 1995, 332(16):1077-1082.
2. Arsura EL, Kilgore WB: Miliary coccidioidomycosis in the immunocompetent. Chest 2000, 117(2):404-409.
3. Chiller TM, Galgiani JN, Stevens DA: Coccidioidomycosis. Infect Dis Clin North Am 2003, 17(1):41-57, viii.
4. Deresinski SC: Coccidioidomycosis: efficacy of new agents and future prospects. Curr Opin Infect Dis 2001, 14(6):693-696.
5. Galgiani JN, Ampel NM, Catanzaro A, Johnson RH, Stevens DA, Williams PL: Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis 2000, 30(4):658-661.
6. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA, Williams PL: Coccidioidomycosis. Clin Infect Dis 2005, 41(9):1217-1223.
7. Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR: Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis 2005, 40(12):1770-1776.
8. Prabhu RM, Bonnell M, Currier BL, Orenstein R: Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis 2004, 39(7):e74-7.
9. Lutz JE, Clemons KV, Aristizabal BH, Stevens DA: Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis. Antimicrob Agents Chemother 1997, 41(7):1558-1561.
10. Deresinski SC, Stevens DA: Caspofungin. Clin Infect Dis 2003, 36(11):1445-1457.
11. Letscher-Bru V, Herbrecht R: Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother 2003, 51(3):513-521.
12. Gonzalez GM, Tijerina R, Najvar LK, Bocanegra R, Luther M, Rinaldi MG, Graybill JR: Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother 2001, 45(6):1854-1859.
13. Antony S: Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. Clin Infect Dis 2004, 39(6):879-880.
14. Hsue G, Napier JT, Prince RA, Chi J, Hospenthal DR: Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother 2004, 54(1):292-294.
15. Stevens DA: Drug interactions of caspofungin(C) with conventional agents against pathogens of endemic mycoses [abstract M-863]: San Diego. American Society for Microbiology; 2002.